Nihon Medi-Physics Co.,Ltd

■As a leading company in the field of diagnostic radiopharmaceuticals, our mission is to provide a stable supply of high-quality products and to explore new value in nuclear medicine through the development of new products and technologies. We operate businesses in both the "diagnosis" and "treatment" sectors.
■For PET (positron emission tomography) radiopharmaceuticals, which are in high demand, we have established 11 domestic bases to ensure a stable nationwide supply, given that the half-life of the RI contained in these products is extremely short, about two hours.
■As a pioneer in pharmaceuticals approved by the Ministry of Health, Labour and Welfare in Japan, we provide nationwide supply and contribute to the spread of PET examinations in Japan. Additionally, we are currently focusing on the theranostics business, which merges the concepts of diagnosis and treatment, and we are engaged in the development of new drugs from both diagnostic and therapeutic perspectives.